Prolactin (PRL) release-inhibiting properties of the α2 adrenergic receptor antagonist Idazoxan: Comparison with yohimbine
Authors:
- Jana Jur̀čovičováJJJana Jur̀čovičová
- Thuy LeTLThuy Le
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 44 (12) , 809-818
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Alpha-2-Adrenergic Control of Prolactin ReleaseNeuroendocrinology, 1986
- Comparison of the effects of recently developed α2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brainBiochemical Pharmacology, 1985
- Comparison of the ?-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthineNaunyn-Schmiedeberg's Archives of Pharmacology, 1984
- [3H]RX 781094: A new antagonist ligand labels α2-adrenoceptors in the rat brain cortexEuropean Journal of Pharmacology, 1983
- Neuropharmacological studies in rodents on the action of RX 781094, a new selective α2-adrenoceptor antagonistNeuropharmacology, 1983
- Studies on RX 781094: a selective, potent and specific antagonist of α2‐adrenoceptorsBritish Journal of Pharmacology, 1983
- RX781094, a new potent ?2 adrenoceptor antagonistNaunyn-Schmiedeberg's Archives of Pharmacology, 1983
- Noradrenergic Regulation of Growth Hormone Secretion in the Baboon*Endocrinology, 1983
- Differential Effects of Pharmacological Manipulations of Central α1- and a2-Adrenergic Receptors on the Secretion of Thyrotropin and Growth Hormone in Male Rats*Endocrinology, 1982
- A rapid and simple procedure for chronic cannulation of the rat jugular vein.Journal of Applied Physiology, 1974